Page 119 - MBCA_FULL REPORT_FINAL_FOR_WEB
P. 119

Study Drug(s)        Target       Biomarkers/     Combination        Sponsor
                                                            Subtype
                          Eribulin             N/A          All                                University of Washington
                          Eribulin             N/A          Hormone+_HER2-                     Dana-Farber/Harvard Cancer
                                                                                               Center
                          Eribulin             N/A          HER2-                              Eisai
                          Eribulin/cyclophospha-  N/A       All                                University of California, San
                          mide                                                                 Francisco
                          Eribulin/carboplatin  N/A         All                                Eisai
                          Capecitabine/digoxin  N/A         All                                Western Regional Medical
                                                                                               Center
                          FdCyd (5-fluoro-2'-  N/A          All                                National Cancer Institute
                          deoxcytidine) and THU
                          (tetrahydrouridine)
                          Protein-bound paclitaxel  N/A     All                                City of Hope
                          Protein-bound pacli-  N/A         HER2-                              Baylor Research Institute
                          taxel/Anakinra (anti-
                          inflammatory)
       Completed as of 8/1  Protein-bound pacli-  N/A       All                                University of California, San
                          taxel/Lapatinib                                                      Francisco
                          Protein-bound paclitaxel  N/A     All                                IGDRASOL
                          vs. IG-001
       Unknown as of 8/1  Tesetaxel            N/A          HER2-                              Genta
       Unknown as of 8/1  Tesetaxel/capecitabine   N/A      HER2-                              Genta
                          ThermoDox (doxoru-   Chemotherapy All             Hyperthermia therapy Celsion 
                          bicin enhanced with
                          lysolipid thermally sensi-
                          tive liposomes)
       Completed as of 8/1  Heated cisplatin   Chemotherapy All             Surgery            St. Luke's-Roosevelt Hospital
                                                                                               Center 
                          FOLFOX (folinic acid,   Liver metas-  All                            Western Regional Medical
                          fluorouracil, oxaliplatin)/   tases                                  Center
                          hepatic infusion
       Unknown as of 8/1  Oral eniluracil + 5-fluoro-  N/A  All
                          uracil + leucovorin
                          MM-398/irinotecan    N/A          Solid Tumor     Tracer for MRI imaging  Merrimack Pharmaceuticals
                          IMMU-132/irinotecan  N/A          All                                Immunomedics
                          Azacitidine          N/A          HER2-           Protein-bound pacli-  University of Utah
                                                                            taxel
                          Nab-paclitaxel       N/A          TripleNegative  With gemcitabine/   Celgene
                                                                            carboplatin vs. gemi-
                                                                            ctabine/ carboplatin
                                                                            alone
       Unknown as of 8/1  Doxorubicin/heat treat-  N/A      All                                National Center for Research
                          ment                                                                 Resources (NCRR)
                          Ixabepilone and stereo-  N/A      TripleNegative                     University of Texas Southwest-
                          tactic radiation                                                     ern
                          EC1456               Folate recep-  TripleNegative                   Endocyte
                                               tors
                          TAS-114              Pyramidine   All             Capecitabine       Taiho Oncology
                                               metabolism
                          Lurbinectedin (PM01183) DNA binding  All          Paclitaxel with or with- PharmaMar
                                                                            out bevacizumab
                          MM-302               ERB2         HER2+           With/without traztu-  Merrimack Pharmaceuticals
                                                                            zumab or cyclophos-
                                                                            phamide
      Other
      Unknown as of 8/1   Whole body hyperther-  Heat       All             Fluorouracil, doxoru-  University of Texas
                          mia                                               bicin
                          Surgery              N/A          All             Radiation          National Cancer Institute
   114   115   116   117   118   119   120   121   122   123   124